Does creatine harm the liver?

No. Long-term studies show no adverse effects of creatine supplementation on liver function. Liver enzyme levels (ALT, AST, GGT) remain within normal ranges during creatine use. The liver's role in creatine metabolism (GAMT reaction) is actually reduced when exogenous creatine is supplemented.

What role does the liver play in creatine metabolism?

The liver performs the second step of creatine biosynthesis using the GAMT enzyme, which methylates guanidinoacetate (GAA) to form creatine. When you supplement with creatine, the AGAT enzyme in the kidneys is feedback-inhibited, producing less GAA, which means the liver has less methylation work to perform.

Should people with liver disease avoid creatine?

People with diagnosed liver disease should consult their hepatologist before taking creatine. While creatine has not been shown to damage healthy livers, individuals with impaired hepatic function may have altered creatine metabolism. The GAMT enzyme in the liver requires SAM, which is also used for other hepatic methylation reactions.

Creatine and Hepatic Function: The Evidence

The Liver in Creatine Metabolism

The liver performs the final step of creatine biosynthesis and is the primary site of the GAMT (guanidinoacetate N-methyltransferase) reaction. Understanding the liver’s role in creatine metabolism clarifies both the safety of supplementation and the metabolic consequences of endogenous versus exogenous creatine supply (T et al., 2011) .

Normal

liver enzyme levels (ALT, AST, GGT) consistently maintained in long-term creatine users across multiple studies

Antonio & Ciccone, 2013

GAMT: The Hepatic Methylation Step

The GAMT enzyme, located in the hepatocytes, catalyzes the final step of creatine synthesis:

GAA + SAM → Creatine + SAH

This reaction transfers a methyl group from S-adenosylmethionine (SAM) to guanidinoacetate (GAA), producing creatine and S-adenosylhomocysteine (SAH).

Key features of hepatic GAMT:

Expressed predominantly in the liver, with minor expression in other tissues
Consumes approximately 40% of all hepatic SAM-dependent methylation
Activity is regulated indirectly by AGAT feedback — when creatine levels are high, AGAT produces less GAA, reducing GAMT substrate availability
The reaction is not rate-limiting under normal conditions (GAMT has excess capacity)

Impact of Supplementation on Liver Workload

Creatine supplementation paradoxically reduces the liver’s creatine-related workload (RB et al., 2017) :

Before supplementation:

Kidneys produce approximately 1-2g of GAA daily via AGAT
GAA travels to the liver via the bloodstream
Liver GAMT methylates all of this GAA to creatine
This consumes approximately 40% of hepatic SAM

After supplementation:

Exogenous creatine raises intracellular creatine levels
Elevated creatine feedback-inhibits renal AGAT
Less GAA is produced and delivered to the liver
GAMT has less substrate to methylate
Less SAM is consumed for creatine synthesis
More SAM is available for other hepatic methylation reactions (detoxification, phospholipid synthesis, bile acid conjugation)

This reduced methylation burden is actually beneficial for liver function, freeing SAM for other important hepatic processes.

Hepatic SAM and Liver Health

SAM is critically important for liver health:

Phosphatidylcholine synthesis: SAM-dependent methylation of phosphatidylethanolamine produces phosphatidylcholine, essential for cell membranes and VLDL secretion
Glutathione synthesis: SAM feeds into the transsulfuration pathway, producing cysteine for glutathione (the liver’s primary antioxidant)
Detoxification: Phase II hepatic detoxification includes SAM-dependent methylation of xenobiotics
Bile acid conjugation: proper bile acid metabolism requires methylation

By reducing the SAM drain from creatine synthesis, supplementation may actually support these other hepatic SAM-dependent functions.

Long-Term Liver Safety Evidence

Antonio & Ciccone (2013) (J & V, 2013) :

Athletes using creatine for 0.8 to 5 years
Comprehensive metabolic panel including liver enzymes
ALT (alanine aminotransferase): normal
AST (aspartate aminotransferase): normal
No evidence of hepatotoxicity

ISSN Position Stand (Kreider et al., 2017):

Reviewed all available safety data on creatine and liver function
No scientific evidence of adverse hepatic effects
Stated that creatine supplementation does not damage the liver in healthy individuals

Multiple shorter-term studies (weeks to months):

Consistently show normal liver enzyme levels during creatine supplementation
No dose-dependent liver toxicity observed even at high loading doses (20-30g/day for short periods)

Liver Disease Considerations

While creatine is safe for healthy livers, individuals with liver disease should exercise caution:

Non-alcoholic fatty liver disease (NAFLD):

NAFLD involves impaired hepatic lipid metabolism and inflammation
SAM metabolism may be altered in NAFLD
Theoretical concern: reduced GAMT function could alter creatine synthesis
No direct evidence that creatine worsens NAFLD; some researchers suggest it could be beneficial via SAM sparing

Alcoholic liver disease:

Alcohol depletes hepatic SAM stores
Impaired SAM availability affects GAMT function
Creatine supplementation (by reducing SAM demand) could theoretically be beneficial
However, clinical evidence is lacking; consult physician

Cirrhosis:

Severely impaired liver function affects all hepatic metabolic pathways
GAMT activity may be significantly reduced
Supplementation should only be considered under medical supervision

Creatine and Liver Detoxification

An underappreciated benefit of creatine supplementation relates to hepatic detoxification capacity:

The liver uses SAM for Phase II methylation reactions that detoxify various substances including environmental toxins, hormones (estrogen metabolism), and pharmaceutical drugs. By freeing up SAM that would otherwise be consumed by GAMT for creatine synthesis, supplementation may enhance the liver’s overall detoxification capacity.

This is speculative but biochemically logical and represents an interesting area for future research.

Summary

The liver performs the final step of creatine biosynthesis (GAMT reaction), consuming approximately 40% of hepatic SAM. Creatine supplementation reduces this biosynthetic demand by feedback-inhibiting the upstream AGAT enzyme in the kidneys, effectively decreasing the liver’s workload and freeing SAM for other critical hepatic functions. Long-term studies confirm no adverse effects on liver enzyme levels or hepatic function in healthy individuals. Individuals with pre-existing liver disease should consult their physician before supplementation.